S203: QUADRUPLET INDUCTION THERAPY, ASCT AND MRD-MODULATED CONSOLIDATION AND TREATMENT CESSATION IN NEWLY DIAGNOSED MULTIPLE MYELOMA: FINAL ANALYSIS OF THE MASTER TRIAL

• Luciano Costa,
• Eva Medvedova,
• Sarabh Chhabra,
• Bhagirathbhai Dholaria,
• Binod Dhakal,
• Kelly Godby,
• Rebecca Silberman,
• Susan Bal,
• Anita D’souza,
• Smith Giri,
• Timothy Schmidt,
• James Omel,
• Parameswaran Hari,
• Natalie Callander

Affiliations

Luciano Costa

1 University of Alabama at Birmingham, Hematology and Oncology, Birmingham, United States

Eva Medvedova

2 Oregon Health and Science University, Portland, United States

Sarabh Chhabra

3 Medical College of Wisconsin, Milwaukee, United States

Bhagirathbhai Dholaria

4 Vanderbilt University Medical Center, Nashville, United States

Binod Dhakal

3 Medical College of Wisconsin, Milwaukee, United States

Kelly Godby

1 University of Alabama at Birmingham, Hematology and Oncology, Birmingham, United States

Rebecca Silberman

2 Oregon Health and Science University, Portland, United States

Susan Bal

1 University of Alabama at Birmingham, Hematology and Oncology, Birmingham, United States

Anita D’souza

3 Medical College of Wisconsin, Milwaukee, United States

Smith Giri

1 University of Alabama at Birmingham, Hematology and Oncology, Birmingham, United States

Timothy Schmidt

5 University of Wisconsin-Madison, Medicine, Madison, United States

James Omel

6 Omaha, Omaha, United States

Parameswaran Hari

3 Medical College of Wisconsin, Milwaukee, United States

Natalie Callander

5 University of Wisconsin-Madison, Medicine, Madison, United States